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Abstract
Introduction—Vitamin D has pleiotropic functions that regulate fetal growth and development.
We investigated associations of common placental genetic variations in vitamin D metabolism
with birthweight.
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Methods—The study was conducted among participants (506 maternal-infant pairs) of a
pregnancy cohort study. Data were collected using interviewer-administered questionnaires and
post-delivery medical record abstraction. DNA, extracted from placental samples collected at
delivery, was genotyped for eight single nucleotide polymorphisms (SNPs) in five vitamin D
metabolism genes (CUBN, LRP2, VDR, GC, and CYP2R1). Linear and logistic regression models
were used to evaluate associations of SNPs with birthweight and risk of low birthweight,
respectively. Effect modification of associations by infant sex was examined using stratified
analyses and interaction terms in regression models
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Results—Mean (standard-deviation) birthweight among all, male, and female infants was
3,482.1 (549.9), 3,544.6 (579.0) and 3,419.2 (512.5) grams, respectively. Each copy of the minor
allele of rs2282679 (GC) was associated with a 68.6g (95%CI:3.1,134.7g) increase in birthweight
overall. Sex-specific associations were observed for SNP rs4667591 (LRP2) (p-value for
interaction < 0.001). Each copy of the minor allele of rs4667591 was associated with a 124.7g
(95%CI:20.1,229.0g) increase in birthweight among female infants, and a suggested 81.6g
decrease in birthweight among male infants (95%CI:-183.7,20.5g).
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Discussion—Our study identified overall and sex-specific associations between placental
genetic variations in vitamin D metabolism and birthweight. If confirmed by larger replication
studies, observed associations may provide insight into mechanistic underpinnings of the
relationships between placental vitamin D metabolism and birth size.
Keywords
Birthweight; vitamin D; placenta; genetic variation

INTRODUCTION
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Vitamin D is a pleiotropic hormone that is important in fetal growth, development, and
programming [1]. Maternal vitamin D deficiency is a major public health concern that has
been linked with poor birth outcomes, including fetal growth restriction, [2-5] a risk factor
for life course morbidity and mortality [6]. However, underlying mechanisms of these
relationships have not been fully described. Findings from several studies suggest the
importance of maternal or fetal genetic variations in vitamin D metabolism [7, 8]. Despite
the role of the placenta in vitamin D metabolism, including conversion of 25hydroxyvitamin D to its biologically active form, [9, 10] and presence of functional vitamin
D receptors in the placenta, whether placental genetic variations in vitamin D metabolism
are associated with birthweight remains unexplored.

Author Manuscript

The placenta is a highly complex organ that plays an active role in fetal growth,
development, and programming in addition to serving as the maternal-fetal interface [11].
Vitamin D acts through VDR and cAMP/protein kinase A signaling pathways to regulate
human chorionic gonadotropin expression, its secretion in human synctiotrophoblasts, [12]
and placental sex steroid production [13]. In addition, vitamin D plays a role in glucose
availability for trans-placental transport [14]. As a regulator of calcium homeostasis and
transport, it can influence fetal growth through the promotion of skeletal muscle and bone
development [15]. Therefore, placental genetic variations that are involved in vitamin D
metabolism may be associated with fetal growth. These associations could potentially be
sex-specific, given differences in fetal growth trajectories and birthweight between male and
female infants [16] as well as previous reports of differences in vitamin D-birthweight
associations between male and female infants [17]. We investigated overall and infant sexspecific associations of placental genetic variations related to vitamin D metabolism with
birthweight.

METHODS
Author Manuscript

Study Setting and Study Population
The setting for the current study was the Omega study, a cohort study of dietary and
metabolic risk factors associated with adverse pregnancy outcomes. Briefly, Omega study
participants were recruited between 1996 and 2008 at prenatal care clinics affiliated with the
Swedish Medical Center in Seattle, Washington and Tacoma General Hospital, Tacoma,
Washington [18]. Eligible participants included pregnant women who initiated prenatal care
at or before 20 weeks gestation, were aged ≥ 18 years, able to speak and read English,
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planned to carry the pregnancy to term, and to deliver at either of the two hospitals.
Participants who provided placental samples (between 2004 and 2008) at delivery (N=547)
were included in the current study. After excluding 28 participants with gestational diabetes
mellitus, ten participants with preeclampsia, and three participants with missing infant sex, a
total of 506 participants remained for analyses. The Institutional Review Boards of Swedish
Medical Center and Tacoma General Hospital approved the study protocol. All participants
provided informed consent.
Data Collection
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Trained personnel conducted in-person interviews in early pregnancy, soon after recruitment,
to obtain information on maternal socio-demographic and medical characteristics, family
and medical history, dietary intake, and life style habits (e.g. smoking and physical activity).
Participants provided peripheral blood samples during this visit. Serum 25-hydroxyvitamin
D concentrations were measured using liquid chromatography-tandem mass spectrometry
(LC-MS/MS) by ZRT Laboratory (ZRT Laboratory, Portland, OR). Both 25-hydroxyvitamin
D2 and 25-hydroxyvitamin D3 concentrations were measured, with the sum giving total
serum 25-hydroxyvitamin D concentration. At the end of pregnancy, medical records were
abstracted to obtain information on the course and outcomes of pregnancy, including
information on infant birth characteristics.
In addition, at delivery, placenta samples were collected. Placenta specimens were doublebagged, placed into coolers, and transported to a dedicated placenta-processing laboratory.
Biopsy samples were taken using a systematic technique to achieve uniformity and adequate
sampling as described before [19]. Biopsy samples were placed into cryotubes and stored at
−80 °C until processing.
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SNP Selection and Genotyping
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For the current study, we used the available literature to identify eight single nucleotide
polymorphisms (tag-SNPs) located in five candidate vitamin D metabolism genes that have
been associated with vitamin D levels: CUBN (rs1801231, rs1801224 and rs1801222),
LRP2 (rs4667591 and rs2229263), VDR (rs2228570), GC (rs2282679), and CYP2R1
(rs10741657) [20-22]. DNA was extracted from placenta tissues using the QIAamp Tissue
Kit (QIAGEN Inc. Chatsworth, CA) following the manufacturer's instructions. DNA was
quantified with the PicoGreen Quant-iT dsDNA Assay Kit (Thermo Fisher Scientific, Grand
Island, NY) and a SpectraMAXGeminiXPS Spectrofluorometric Micro plate reader.
Genotyping was conducted using Sequenom/Agenaiplex platform. Briefly, the protocol
involves PCR amplification of DNA using SNP specific primers, from Integrated DNA
Technologies (Coralville, IA), followed by a base extension reaction using the iPLEX Gold
Chemistry (Agena, San Diego, CA). The treated extension product was spotted to the
appropriate location on a 384-pad SpectroCHIP II using a SequenomMassARRAY
Nanodispenser (Agena, San Diego, CA). A MassARRAY Analyzer Compact MALDI-TOF
MS (Agena, San Diego, CA) was used for data acquisitions from the SpectroCHIP. All
resultant genotyping calls were performed in real time by the MassARRAYTyper Analyzer
v4.0.26.73 (Agena, San Diego, CA). Data was exported into a Microsoft Excel spreadsheet.
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Infant birthweight was abstracted from medical records. Birthweight was analyzed as a
continuous variable in grams. In addition, < 2500 grams of birthweight was used to define
low birthweight, which was analyzed as a categorical variable.
Statistical Analysis
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Maternal and infant characteristics were summarized as follows. Continuous variables were
described using mean ± standard deviation (SD) and categorical variables were described
using counts and proportions for all participants (overall and stratified by infant sex). Minor
allele frequency (MAF) of each SNP was calculated and Hardy Weinberg Equilibrium
(HWE) was examined. Linear regression models were used to evaluate independent
associations of each SNP with birthweight. This model assessed average birthweight
difference per added copy of each minor allele among all infants, as well as separately for
male and female infants. Similarly, logistic regression models were used when assessing risk
of low birthweight in relation to each minor allele. Linear and logistic regression models
were adjusted for infant sex (except for sex-specific models), gestational age at delivery and
maternal race/ethnicity (non-Hispanic white/other).
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We also conducted exploratory analyses using weighted genetic risk scores (wGRS), for all
participants and male/female infants separately, computed by risk allele counting method
weighted by individual effect estimates of the variants [23]. Regression models, similar to
those described above, were fit to examine overall and sex-specific associations of wGRS
with birthweight and risk of low birthweight, adjusted for race and gestational age. In all
analyses, multiple testing corrections were not applied given the exploratory nature of the
analyses, the relatively small number of SNPs evaluated, and selection of strong candidate
genes and SNPs from the literature. Statistical analyses were conducted using SAS 9.4 (SAS
Institute, Cary NC) and R 3.2.3 software.

RESULTS
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Selected characteristics of study participants are shown in Table 1. Average maternal early
pregnancy serum 25-hydroxyvitamin D concentration was 29 ng/mL (SD=9.5 ng/mL).
Approximately 88.1% of mothers were non-Hispanic White and 49.8% delivered female
infants. Mean birthweights among all, male and female infants were all, male, and female
infants was 3,482.1 (SD=549.9), 3,544.6 (SD=579.0) and 3,419.2 (SD=512.5) grams,
respectively. The eight SNPs used to characterize variations in five vitamin D-metabolism
genes are shown in Table 2. Genotype frequencies of all SNPs were in Hardy-Weinberg
equilibrium and the SNPs minor-allele frequencies ranged from 0.03 to 0.14.
In the multivariable adjusted model (Table 3), each copy of the minor allele of rs2282679
(GC) was associated with a 78.6 g (95%CI:11.1,146.2g) increase in birthweight overall (pvalue=0.04). Sex-specific associations were observed for SNP rs4667591 (LRP2) (p for
interactions <0.001). Each copy of the minor allele of rs4667591 was associated with 124.6
g (95%CI:20.1,229.0g) increase in birthweight among female infants, but suggests a −81.6g
(95%CI:−183.7,−20.5g) decrease in birthweight among male infants. Similar, but less
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pronounced sex-specific differences were observed for SNP rs1801231 (CUBN) (p-value for
interactions=0.03). Each copy of the minor allele of rs1801231 was associated with a
suggested 62.3g (95%CI:−54.1,178.7g) increase in birthweight among female infants, but a
suggested 67.6g (95%CI:−188.2,53.0g) decrease in birthweight among male infants. wGRS
of evaluated genetic variations was positively associated with the continuous measure of
birthweight in overall models (1.4g, 95%CI:0.4,2.3g), but not in sex-stratified models or in
models where low birthweight was the outcome.

DISCUSSION
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In this study, we found evidence for associations of placental genetic variants in vitamin D
metabolism with birthweight overall (in GC gene) and by infant sex (in LRP2 and CUBN
genes). We also observed sex-specific differences in these associations where risk variants in
the LRP2 and CUBN genes were associated with higher birthweight among females but
suggesting lower birthweight among males. wGRS of the examined candidate SNPs was
significantly associated with increased birthweight in overall models, but not sex-stratified
models.
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To our knowledge, this is the first study investigating placental genetic variations in vitamin
D metabolism with birth size. Recently, Nguyen et al demonstrated that placental 25hydroxyvitamin D levels and placental VDR mRNA expression are significantly decreased
in pregnancies affected by idiopathic fetal growth retardation (defined as a birthweight of
less than the 10th percentile for gestation) compared with uncomplicated gestation-matched
control pregnancies [24]. Bodnar et al and Swamy et al showed that maternal SNPs in VDR
influence birthweight and risk of small-for-gestational age (SGA) (defined as live-born
infants at <10th percentile) among white mothers and black mothers, respectively [8, 25]. In
their fully adjusted model, Bodnar et al found that risk of SGA was increased by 1.7-fold
(95% CI:1.1,2.8) per each copy of the rs11168292 allele. Their study did not find
associations of SGA with rs2228570, the VDR SNP we included in our study. It is
interesting to note that we observed potential sex-specific differences in associations of
rs2228570, which did not reach statistical significance. Our study did not evaluate the
rs11168292 SNP. A recent Mendelian randomization study demonstrated that vitamin D
deficiency related GRS characterized using rs10741657 (CYP2R1, also included in our
study) and rs12785878 (DHCR7) maternal SNPs was associated with lower birthweight
[26]. Birthweight was lower by 6g (95%CI:−12, 0g) per unit change in their adjusted GRS,
suggesting evidence for a possible causal association of maternal vitamin D deficiency with
offspring birthweight. In our study, we did not evaluate the rs12785878 (DHCR7) SNP,
while placental variation in the rs10741657 (CYP2R1) was not associated with birthweight.
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Associations between birth size and genetic variants, either maternal or fetal, in GC, CUBN,
or LRP2 have not been reported before. Two copies of the minor allele of fetal rs2282679
SNP in GC was associated with risk of vitamin D insufficiency (OR = 2.76, 95% CI:
1.34-5.69) among 12 month old Caucasian infants (N=491) [27]. The role of vitamin D
binding protein, the protein encoded by GC, on placental trophoblast growth and
development, course of pregnancy and offspring has been well documented [9]. This protein
is important in the transport of vitamin D in the circulatory system. Thus, it is hypothesized
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that variation in GC could influence the facilitated transport of vitamin D into the cell. The
expression of CUBN (cublin or intrinsic factor cobalamin receptor) in the placenta has been
shown to increase with gestation [28]. This increase implied that cubilin may be important in
placental functions, related to maternal-fetal nutrient transfer [28]. Gene expression analysis
by Sabri et al revealed that LRP2 was downregulated in four placentas from fetal growth
restricted pregnancies but not among 11 placentas from macrosomic or normal-term
pregnancies [29]. LRP2 (low density lipoprotein-related protein 2) or megalin, is a multiligand endocytic receptor. It is critical for the reuptake of numerous ligands, including
vitamin-binding proteins. This protein also has a role in cell-signaling. Overall, these reports
support the argument for potential roles of placental genetic variants of these genes in fetal
growth and development.
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Our study also demonstrated potential sex-specific differences in associations of placental
genetic variants related to vitamin D metabolism with birthweight. Available literature
suggests that the beneficial effect of maternal vitamin D may differ among male and female
offspring [17]. Findings by Gernand et al highlight infant sex-specific protective effect of
maternal vitamin D in low birthweight risk [17]. Only female fetuses exhibited reduced
birthweight in the setting of placental vascular pathology and maternal vitamin D deficiency.
A reduced birthweight z-score with lower (<30 nmol/L) maternal 25(OH)D concentration
was observed (β = −0.73; 95%CI:−1.17,−0.30) in females. We evaluated associations
between maternal serum vitamin D and infant birthweight in the current study. In sexspecific models a 10 ng/ml increase in maternal serum vitamin D was associated with −7.7 g
decrease in birthweight (95% CI: −92.6, 77.2 g) among female infants while it was
associated with an 8.2 g increase in birthweight (95% CI: −104.8, 121.3 g) among male
infants. Although not statistically significant, directions of association were different
between males and females, similar to our observations for several of the vitamin D related
SNPs. Differences in genetic/epigenetic markers of placental development and function in
male and female fetuses, and their downstream effects in relation to vitamin D metabolism
may contribute to observed sex-specific differences. This research area is underdeveloped
and needs further investigations in large study populations.

Author Manuscript

Only few studies have assessed vitamin D-related genotypes and their relationships with
birthweight. Our study extends this work by demonstrating associations of vitamin D related
genetic variations with birthweight in a well-characterized study population. The current
study is unique in its assessment of placental genetic variations, as compared to maternal
genetic variation in previous studies, and evaluation of potential sex-specific differences in
associations. Placental genotyping is a key strength because several vitamin D-related genes,
including the ones reported here, are highly expressed in the placenta and decidual tissues in
early gestation and placenta is an important component of the intrauterine environment [30,
31]. It also highlights the potential merit of evaluating both maternal and placental genetic
variations, and their interactions, in this research area. There are also notable limitations of
our study. First, our study may be underpowered to detect significant associations between
several of our SNPs and birthweight. In our study population, several SNPs were observed to
have low MAF. The individual SNP association findings were not adjusted for multiple
testing, although strong priors for our candidate genes exist in other studies. Placental
features, including morphology and gene expression were not evaluated in our study. Our
Placenta. Author manuscript; available in PMC 2018 February 01.
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observations that minor alleles in rs2282679 (GC) and rs4667591 (LRP2) are associated
with increased birthweight overall or in sex-specific models need careful considerations. In
our study population, the C allele of rs2282679 (GC) was associated with −6.0 ng/mL (95%
CI:−10.5,−1.6 ng/mL; p-value=0.01) lower maternal vitamin D level among all participants
and male infants (β=−6.4 ng/ml; 95% CI:−12.5,−0.2 ng/mL; p-value=0.04), but not among
female infants (β=−5.4 ng/ml; 95% CI:−12.1,1.3 ng/mL; p-value=0.11). Overall or sexspecific associations of rs4467591 (LRP2) and maternal vitamin D level was not observed.
The observation for inverse association of rs2282679 (GC) with maternal vitamin D status is
not consistent with our positive rs2282670-birthweight association but similar observation of
inverse association of vitamin D with birthweight is not new to the literature. In a systematic
review, Harvey et al. reported that six studies demonstrated significant positive associations
between maternal vitamin D and offspring birthweight while seven studies reported nonsignificant positive associations [32]. On the other hand, one study reported significant
negative association while three others found non-significant negative associations [32]. The
observed increased in birthweight related to the minor alleles of the SNPs, may not be an
indicator of fetal health, and it cannot exclude other adverse fetal effects (e.g. reduced bone
mass) [33,34]. Therefore, associations between vitamin D and birthweight, and, the role of
genetic risk factors (such as the variants we report in the current study) and modifiers are
important future areas of research.
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One concern in the current study is potential contamination of placental DNA with maternal
DNA. During sample collection, we minimized contamination of placental specimen by
maternal blood. Specimen for genotyping reported in this study was obtained from placental
tissue. Our quality control procedures that involved Hardy Weinberg Equilibrium assessment
minimize potential concerns of contamination. We also had maternal genotype information
for a small subset (N=40) participants in our current study. Our assessment of this data was
reassuring with respect to potential contamination of maternal and placental DNA. Lastly,
our study may not be generalizable to other populations, since our sample consists of 88%
Non-Hispanic Whites.

Author Manuscript

In conclusion, selected vitamin D-related genetic variations in the placenta are associated
with birthweight. Our results also suggest that these associations may be infant sex-specific.
Further research in this area may enhance mechanistic understanding of the relationships
between vitamin D metabolism (e.g. synthesis and transport) and birth size. It may also help
identify susceptible populations for targeted preventative efforts. Future investigations
involving large number of study samples, characterization of additional vitamin D-related
genotypes (maternal and placental), functional assessment of identified genotypes (e.g. gene
and protein expression), and maternal-fetal genetic interactions on maternal and fetal
outcomes are warranted.
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Highlights
•

Vitamin D-related genetic variations in the placenta are associated with
birthweight.

•

Suggestive evidence supports potential infant sex-specific differences in
associations of vitamin D-related genetic variations with birthweight.

•

Findings may improve mechanistic understanding of the relationships
between maternal vitamin D, placental vitamin D metabolism, and birth size.

Author Manuscript
Author Manuscript
Author Manuscript
Placenta. Author manuscript; available in PMC 2018 February 01.

Workalemahu et al.

Page 11

Table 1

Author Manuscript

Selected characteristics of study participants
All Infants

§

§
Females

Males

§

506

252

254

Maternal age, y

33.6 ± 4.3

33.7 ± 4.4

33.5 ± 4.2

Gestational age, y

38.8 ± 1.9

38.9 ± 1.4

38.9 ± 1.6

Gestational age at blood draw, wk

16.4 ± 1.9

16.5 ± 2.0

16.3 ± 1.8

Pre-pregnancy BMI, kg/m2

23.7 ± 4.6

23.6 ± 4.7

23.8 ± 4.6

N

29.1 ± 9.5

29.4 ± 10.5

28.8 ± 8.5

3482.1 ± 549.9

3419.2 ± 512.5

3544.6 ± 579.0

Infant head circumference, cm

35.1 ± 2.6

34.8 ± 2.4

35.4 ± 2.7

Married, n (%)

469 (92.1)

235 (93.3)

231 (90.9)

≥ High school education, n (%)

452 (97.4)

226 (97.8)

225 (97.0)

Physically active during pregnancy, n (%)

427 (93.4)

211 (92.1)

215 (94.7)

Never

349 (76.5)

173 (75.9)

175 (77.1)

Quit before pregnancy

92 (20.1)

44 (19.3)

48 (21.2)

25-hydroxyvitamin D, ng/mL
Infant birthweight, g
Infant low birthweight, n (%)

Author Manuscript

Smoking status, n (%)

Smoked during pregnancy
Non-Hispanic White, n (%)

15 (3.3)

11 (4.8)

4 (1.8)

451 (88.6)

214 (84.9)

235 (92.5)

§

values are means ± standard deviation, unless otherwise stated
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Table 2

Author Manuscript

Placental Vitamin D Metabolism and Fetal Growth Related Single Nucleotide Polymorphisms
Gene

Name

Location

SNP

Chr

a

Minor Allele

b

c

MAF

HWE

Vitamin D Metabolism Related Genotypes

Author Manuscript

a

CUBN

intrinsic factor-cobalamin receptor

Coding

rs1801231

10

C

0.03

0.130

CUBN

intrinsic factor-cobalamin receptor

Coding

rs1801224

10

C

0.10

0.620

CUBN

intrinsic factor-cobalamin receptor

Coding

rs1801222

10

T

0.11

0.480

LRP2

low density lipoprotein receptor-related protein

Coding

rs4667591

2

T

0.06

0.410

LRP2

low density lipoprotein receptor-related protein

Coding

rs2229263

2

G

0.10

0.410

VDR

vitamin D (1,25-dihydroxyvitamin D3) receptor

Coding

rs2228570

12

T

0.14

0.100

GC

vitamin D binding protein

Intronic

rs2282679

4

C

0.08

0.590

CYP2R1

cytochrome P450, family 2, subfamily R, polypeptide

5’ upstream

rs10741657

11

A

0.14

0.930

Chromosome

b

Minor allele frequency

c

Hardy Weinberg Equilibrium p-value
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Table 3

Author Manuscript

Multi-variable adjusted association between birthweight and placental vitamin D metabolism-related
genotypes
Birthweight in grams
Locus (Index SNP, Effect allele/
Other allele)

a

All infants

Female Infants

Male Infants

b
Low birthweight (< 2500
grams)

N=506

N=252

N=254

N=24 (4.7%)

CUBN (rs1801231,C/T)

−13.1 (−96.7, 70.5)

62.3 (−54.1, 178.7)

−67.6 (−188.2, 53.0)

1.26 (0.39 - 4.05)

CUBN (rs1801224,C/A)

0.65 (−70.1, 71.4)

−33.5 (−131.3, 64.2)

27.3 (−74.1, 128.6)

1.04 (0.33 - 3.28)

CUBN (rs1801222,T/C)

−18.6 (−85.9, 48.8)

−31.3 (−121.3, 58.8)

−31.3 (−132.7, 69.6)

2.06 (0.76 - 5.57)

LRP2 (rs4667591,T/G)

7.6 (−65.2, 80.3)

−81.6 (−183.7, 20.5)

1.04 (0.34 - 3.22)

**

124.6

(20.1, 229.0)

Author Manuscript

LRP2 (rs2229263,G/A)

17.2 (−47.2, 81.7)

22.4 (−65.0, 109.7)

−2.7 (−100.8, 95.3)

1.16 (0.47 - 2.88)

VDR (rs2228570,T/G)

−4.8 (−69.1, 59.6)

−35.1 (−123.4, 53.2)

50.7 (−42.9, 144.3)

1.92 (0.71 - 5.19)

57.7 (−36.1, 151.4)

94.6* (−3.3, 192.4)

0.53 (0.18 – 1.62)

**

GC (rs2282679,C/A)

78.6

(11.1, 146.2)

CYP2R1 (rs10741657,A/G)

−3.8 (−66.4, 58.8)

−2.6 (−88.4, 83.3)

−16.7 (−107.9, 74.5)

1.89 (0.75 - 4.75)

Genetic risk Score (GRS)

1.36 (0.41, 2.30)

0.29 (−0.22, 0.80)

0.41 (−0.09, 0.90)

0.98 (0.99 - 1.01)

Note: P-values for sex interaction: rs4667591 (0.001), rs1801231 (0.03)

a

β (95% CI), adjusted for sex, race and gestational age (only race and gestational age included for sex-specific models)

b

OR (95% CI), adjusted for sex, race and gestational age

**
Statistically significant estimates
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